Institute scientist named as ‘Future Leader’ by Cancer Research UK

06 November 2017

Dr Santiago Zelenay from the CRUK Manchester Institute has received Cancer Research UK’s Future Leader Prize at the NCRI Cancer Conference in Liverpool this week.

He is an immunologist who is building an exciting research programme looking at the cellular and molecular mediators that regulate anti-cancer immunity. His discovery that prostaglandin E2 production by cancer cells enables immune escape has raised exciting new ideas for targeted approaches adjuvant to immunotherapy.

Santiago joined the Institute as a junior group leader in 2015, following a postdoc in Professor Caetano Reis e Sousa's group at the Francis Crick Institute, where he secured EMBO and Marie Curie Fellowships. His PhD, on the origin and function of regulatory T cells, was awarded in 2008 by Portugal's Instituto Gulbenkian de Ciência.

He said: “I am extremely honoured and grateful to Cancer Research UK and the panel for selecting me for this prestigious award. I feel very proud to be now part of a list of awardees that includes so many distinguished and accomplished investigators. In a way, given that the prize is for “Future” Leaders in Cancer Research I cannot also help but feel that the pressure is really on. I hope to live up to expectations.”

The Future Leaders in Cancer Research Prize recognises researchers who have produced research of international importance within 10 years of receiving their doctorate, and proved themselves capable of becoming leaders in the field. This year Cancer Research UK have awarded this prize to three recipients: Dr Zelenay, Dr Gert Attard at The Institute of Cancer Research and Dr Simon Leedham from the Wellcome Trust Centre for Human Genetics.